Skip to main content

Table 6 Changes in out-of-clinic time use by domains (MARCA; min/day) in the standard clinic (C) and the text message-enhanced clinic (EC)

From: Feasibility, acceptability and efficacy of a text message-enhanced clinical exercise rehabilitation intervention for increasing ‘whole-of-day’ activity in people living with and beyond cancer

   Week 4 (clinic cessation) Week 12 (text cessation) Week 12-Week 4
n M (95%CI) P n M (95%CI) P M (95%CI) p
Chores (min/day) C 17 −19.2 (−51.9, 13.5) 0.249 15 −26.3 (−64.5, 11.9) 0.177 −7.1 (−47.7, 33.6) 0.734
EC 18 −21.5 (−53.0, 10.1) 0.182 15 −11.1 (−49.2, 27.0) 0.568 10.4 (−29.9, 50.7) 0.614
EC-C   −2.2 (−50.1, 45.7) 0.928   15.2 (−41.0, 71.4) 0.5962 17.4 (−39.8, 74.6) 0.550
Cultural C 17 −2.0 (−11.6, 7.6) 0.682 15 −4.7 (−6.6, − 2.9) < 0.001 − 2.7 (− 13.2, 7.8) 0.612
EC 18 −0.2 (−9.5, 9.1) 0.964 15 −4.7 (−6.6, − 2.9) < 0.001 − 4.5 (− 14.7, 5.6) 0.382
EC-C   1.8 (−11.6, 15.2) 0.794   0.0 (−2.8, 2.7) 0.978 −1.8 (− 16.4, 12.8) 0.806
Physical Activity C 17 8.1 (−0.1, 16.4) 0.054 15 17.1 (2.7, 31.5) 0.020 9.0 (−1.9, 19.9) 0.107
EC 18 9.1 (1.1, 17.1) 0.026 15 14.8 (0.6, 29.0) 0.041 5.8 (−5.2, 16.7) 0.301
EC-C   0.9 (−11.3, 13.1) 0.881   −2.3 (−22.9, 18.3) 0.828 −3.2 (−18.6, 12.2) 0.682
Quiet time C 17 7.2 (−17.8, 32.3) 0.571 15 28.0 (−4.5, 60.4) 0.091 20.7 (−15.1, 56.5) 0.256
EC 18 −14.7 (−38.9, 9.5) 0.233 15 −35.3 (−67.7, −2.9) 0.033 −20.6 (−56.1, 14.9) 0.256
EC-C   −21.9 (−58.4, 14.6) 0.239   −63.3 (−110.5, − 16.0) 0.009 −41.3 (−91.8, 9.1) 0.108
Screen time C 17 15.1 (−32.0, 62.1) 0.530 15 1.4 (−56.7, 59.5) 0.962 −13.7 (−61.5, 34.2) 0.576
EC 18 13.3 (−32.0, 58.7) 0.564 15 −48.6 (−106, 8.8) 0.097 −1.7 (−70.8, 67.3) 0.960
EC-C   −50.0 (− 134.8, 34.7) 0.247   −62.0 (− 109.7, − 14.2) 0.011 − 48.3 (− 115.9, 19.3) 0.161
Self-care C 17 −1.9 (− 18.3, 14.4) 0.818 15 3.8 (−12.1, 19.7) 0.638 5.7 (−12.6, 24.1) 0.541
EC 18 1.7 (−14.2, 17.5) 0.836 15 0.5 (−15.3, 16.4) 0.949 −1.1 (− 19.3, 17.0) 0.901
EC-C   3.6 (−20.2, 27.4) 0.768   −3.3 (− 26.9, 20.3) 0.784 −6.9 (− 32.7, 18.9) 0.601
Social C 17 −41.0 (−67.9, −14.1) 0.003 15 −22.3 (−62.2, 17.6) 0.274 18.7 (−18.6, 56.0) 0.326
EC 18 −22.5 (−47.9, 2.8) 0.081 15 0.2 (−39.5, 39.8) 0.994 18.4 (−22.0, 58.8) 0.371
EC-C   22.4 (−36.5, 81.3) 0.455   22.7 (−14.5, 59.9) 0.232 4.0 (−48.7, 56.7) 0.881
Transport C 17 4.5 (−23.0, 32.1) 0.747 15 1.2 (−24.4, 26.7) 0.929 −3.4 (−37.9, 31.1) 0.848
EC 18 −6.4 (−33.1, 20.2) 0.636 15 11.8 (−13.8, 37.4) 0.368 18.2 (−15.8, 52.2) 0.294
EC-C   −11 (−50.6, 28.6) 0.587   10.6 (−27.0, 48.2) 0.581 21.6 (−26.9, 70.0) 0.383
Work & Study C 17 −4.9 (−33.3, 23.6) 0.738 15 −3.0 (− 32.8, 26.8) 0.846 1.9 (−23.5, 27.3) 0.883
EC 18 26.9 (−0.7, 54.5) 0.056 15 27.1 (−2.4, 56.5) 0.072 0.2 (−25.1, 25.4) 0.991
EC-C   31.8 (−12.3, 75.8) 0.158   30.0 (− 16.1, 76.1) 0.202 − 1.7 (−37.5, 34.0) 0.924
  1. Table presents mean change over time or mean difference between groups (M) with 95% Confidence Interval (CI) as estimated by mixed models adjusting for baseline values of the outcome, age (years), gender (male/female), time since diagnosis (months) and number of medications currently taken (0/1/≥2). Bold text indicates changes that were significant at p < 0.05